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phase shifts a circadian pacemaker in mammalian SCN. Am. J. 
Physiol. 255 (Regulatory Integrative Comp. Physiol. 24): 
Rl055-Rl058, 1988.-The suprachiasmatic nucleus (SCN) of 
the hypothalamus contains a circadian pacemaker that regu-
lates many circadian rhythms in mammals. Experimental work 
in microorganisms and invertebrates suggests that protein syn-
thesis is required for the function of the circadian oscillator, 
and recent experiments in golden hamsters suggest an acute 
inhibition of protein synthesis can induce phase shifts in a 
mammalian circadian pacemaker. To determine whether pro-
tein synthesis in the SCN region is involved in the generation 
of circadian rhythms in mammals, a protein synthesis inhibitor, 
anisomycin, was microinjected into the SCN region, and the 
effect on the circadian rhythm of locomotor activity of hamsters 
was measured. A single injection of anisomycin into the SCN 
region induced phase shifts in the circadian activity rhythm 
that varied systematically as a function of the phase of injection 
within the circadian cycle. These results suggest that protein 
synthesis may be involved in the generation of circadian 
rhythms in mammals and that the anatomic site of action of 
anisomycin is within the hypothalamic suprachiasmatic region. 
biological rhythms; biological clocks; anisomycin; golden ham-
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THE PERIODIC CHANGE in the physical environment 
throughout the solar day has led to the evolution of 
circadian oscillators that function as biological clocks in 
most, if not all, eukaryotic organisms. The search for the 
anatomic location of the circadian clock in mammals has 
focused on the suprachiasmatic nucleus (SCN) of the 
hypothalamus (13, 18, 24, 26). Destruction of these bi-
laterally paired nuclei leads to the loss of various circa-
dian rhythms in rodents, including the rhythm of wheel-
running activity in hamsters (17). The abolition of cir-
cadian rhythms after SCN lesions is also seen in primates 
(monkeys) (1) and birds (22). In rats, the persistence of 
neural circadian rhythmicity in SCN tissue surgically 
isolated from the rest of the brain (8, 9), as well as in in 
vitro preparations (3, 5, 7, 19), also suggests that the 
SCN contains an autonomous oscillator capable of gen-
erating circadian signals. 
In microorganisms and invertebrates, protein synthe-
sis on 80S ribosomes appears to be involved in the 
generation of circadian rhythms because administration 
of inhibitors of protein synthesis causes phase shifts in 
circadian rhythms (10- 12, 15). We have previously dem-
onstrated that the systemic administration of two protein 
synthesis inhibitors, anisomycin (12 mg/injection) or 
cycloheximide (10 mg/injection), are both effective in 
inducing phase shifts in the circadian activity rhythm of 
hamsters housed in constant darkness (23) . The magni-
tude and direction of the phase shifts are dependent on 
the circadian time of drug treatment. As a first step in 
determining the anatomic location at which inhibition 
of protein synthesis induces phase shifts in mammalian 
circadian rhythms, we examined the effects on the cir-
cadian rhythm of activity of microinjecting microgram 
quantities of anisomycin, a reversible 80S ribosomal 
protein synthesis inhibitor (6), directly into the hy-
pothalamic SCN region of hamsters. 
METHODS 
Adult male golden (Syrian) hamsters (Lakeview Ham-
ster Colony, Newfield, NJ), maintained on a 14:10-h 
light-dark cycle, were stereotaxically implanted under 
pentobarbital sodium anesthesia (60 mg/kg) with ami-
croinjection guide assembly aimed at the SCN region. 
The microinjection guide assembly consists of an outer 
guide tube (23 gauge) and an inner stainless wire pin (0.3 
mm diam), the tip of which is set to extend 1.0 mm 
farther beyond the outer guide cannula. The tip of the 
injection needle (30 gauge), which is connected to a 
microsyringe drive through polyethylene tubing, is de-
signed to extend 0.7 mm beyond the outer guide cannula 
when an injection is made. These configurations leave at 
the tip of the injection needle a small cylindrical space 
-0.3 mm in length and 0.3 mm in diameter into which 
the drug is injected. The stereotaxic coordinates of the 
microinjection guide assembly were 0.2 mm posterior to 
bregma, 1.3 mm lateral to midline with the cannula at a 
go angle, and -7.6 mm ventral from the dura. 
After stereotaxic surgery, the animals were blinded to 
prevent the possibility of light-induced phase shifts in 
the circadian activity rhythm. Once a stable free-running 
rhythm of locomotor activity was established, the ani-
mals received a microinjection of 5 ,.,.g of anisomycin 
dissolved in saline (1 ,.,.1) , or saline alone, into the SCN 
region through the chronically implanted cannula. The 
phase-shifting effects of anisomycin on the free-running 
rhythm of locomotor activity were determined by esti-
mating the steady-state phase of the daily onsets of 
activity before and after the injection as described in 
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FIG. 1. Plot of phase delay in activity rhythm induced by a single 
injection of 5 1-1g of anisomycin presented 12 h after onset of activity in 
hamsters as a function of distance of cannula tip from suprachiasmatic 
nucleus. 
Daan and Pittendrigh (2). The precise nature of the 
onset of wheel-running activity in the hamster makes it 
easy to determine phase shifts as small as 10 min in this 
rhythm. 
At the end of the experiment, animals were perfused 
transcardially, and the brains were examined histologi-
cally to determine the location of t he injection site. In a 
pilot study, we observed that phase shifts in the activity 
rhythm to a 5-JLg dose of anisomycin presented at circa-
dian time 0 were only reliably observed when the cannula 
tip was between 0 and 0.6-0.7 mm from the SCN (Fig. 
1). Therefore, in determining the phase-response curve 
to microinjections of anisomycin, only those animals in 
which the injection site was within 0.5 mm of the SCN 
were included in the analysis of t he data in order to be 
sure that the injection of anisomycin was close enough 
to the SCN to be effective. 
RESULTS 
Administration of anisomycin into the SCN produced 
phase shifts in the activity rhythm that were dependent 
on the circadian time (CT) of the injection. The direction 
and magnitude of phase shifts produced by anisomycin 
microinjected into the SCN region at various times 
t hroughout the circadian cycle are illustrated in Fig. 2. 
Injections of anisomycin at phases between CT 14 and 
CT 4 (CT 12 is by convention represented by the onset 
of locomotor activity in the nocturnal hamster) consist-
ently caused phase delays of~ 1 h in the activity rhythm, 
whereas injections at phases between CT 6 and CT 10 
caused phase advances of a similar magnitude. The ac-
tivity records of representative animals are shown in Fig. 
3 to demonstrate both a phase delay (Fig. 3A) and a 
phase advance (Fig. 3B) in response to the anisomycin. 
Microinjection of saline into t he SCN region had no 
consistent effects on the activity rhythm (Fig. 3C) re-
gardless of the time of administration (Fig. 2C). 
DISCUSSION 
T he results from these experiments suggest that pro-
tein synthesis may be involved in the circadian time-
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FIG. 2. A: phase dependence of effects on locomotor rhythm of 
anisomycin (5 ~tg) microinjections at various circadian times into 
suprachiasmatic nucleus region of hamsters. Each point represents 
phase shift induced in free-running activity rhythm by a single microin-
jection of anisomycin at time indicated on horizontal axis. Circadian 
time (CT) 12 represents time of onset of locomotor activity. Advances 
are plotted as positive values and delays as negative values. B: phase-
response curve for anisomycin microinjections. Each point represents 
mean ± SE phase shift plotted in 2-h bins. Mean phase shifts were 
significantly different from zero at CT 0 and 8, P < 0.001; CT 16 and 
18, P < O.Ql; CT 2, 4, 6, 10, and 22, P < 0.05 (Student's t test). Values 
presented for CT 0 and CT 24 represent same data. C: saline microin-
jections did not cause phase shifts at any phase. Each point represents 
phase shift induced by a single saline microinjection. 
keeping mechanism in the SCN. The shape of the phase-
response curve (PRC) to microinjections of 5.0 p.g ani-
somycin directly into the SCN region (Fig. 2B) is very 
similar in shape to the PRC generated by subcutaneous 
INHIBITION OF PROTEIN SYNTHESIS SHIFTS CIRCADIAN CLOCK R1057 
A 
Hrs 2 4 
8 
0 Hrs 2 -4 
--· : ·3 
~- ::: ~ 
::; ;;;=_:-
c Hrs 24 0 
SAL-
FIG. 3. Representative activity records of free-running hamsters 
microinjected with either anisomycin (ANISO) or saline (SAL) into 
suprachiasmatic nucleus region. Each horizontal line represents activ-
ity record over a single 24-h period and successive days are plotted 
beneath each other. Stars represent times of an injection. A: microin· 
jection of S pg anisomycin at circadian time (CT) 0 induced a phase 
delay in activity rhythm. B: microinjection of S pg anisomycin at CT 
6.5 induced a phase advance of the rhythm. C: microinjection of 1 pi 
saline at CT 0 did not induce a phase shift in rhythm. 
injections of 12 mg anisomycin (23). Thus the effective-
ness of microgram quantities of anisomycin administered 
into the SCN region in phase shifting the circadian 
rhythm of activity is equivalent to the effects of systemic 
administrations with doses more than three orders of 
magnitude greater. Preliminary data from a dose-re-
sponse curve study indicate that the maximum phase 
shift that can be induced by inhibition of protein syn-
thesis is -1-2 h (Inouye, unpublished results). 
Although we have not excluded the possibility that the 
phase-dependent phase shifts of the circadian system o.re 
due to unknown side effects of anisomycin, this seems 
unlikely in view of the results of recent experiments that 
examined the effects of related drugs on the circadian 
activity rhythm of hamsters (23). Both anisomycin and 
cycloheximide decrease catecholamine biosynthesis by 
inhibiting tyrosine hydroxylase activity (20), and both 
also inhibit acetylcholinesterase activity (28, 29). Never-
t heless, peripheral injections of cx-met hyl-p-tyrosine, an 
inhibitor of tyrosine hydroxylase ( 4), and physostigmine, 
an inhibitor of acetylcholinesterase (4), were not effective 
in phase shifting the activity rhythm of hamsters (23). 
Furthermore, subcutaneous injections of anisomycin or 
cycloheximide are both effective in inducing phase shifts 
in the circadian activity rhythm of hamsters despite the 
different mechanisms through which protein synthesis 
is inhibited by these agents (23). 
It is not clear whether the phase shifts induced by 
anisomycin are due to a general reduction of protein 
synthesis or alternatively to an inhibition of a specific 
protein(s) that may be involved in oscillatory function . 
However, in either case, because the phase shifts were 
permanent, anisomycin is acting on the circadian oscil-
lator either directly or indirectly through an input path-
way to the oscillator (24). The presence of both phase 
delays and phase advances in the PRC also suggests that 
the effects of anisomycin are due to an action on a 
specific component of the circadian clock mechanism 
rather than the result of some nonspecific effect on 
metabolism. 
The PRC for the circadian rhythm of locomotor activ-
ity in hamsters to anisomycin injections is quite different 
from the PRC to light pulses (2, 21), indicating that 
anisomycin is perturbing the circadian clock through a 
mechanism different from light. Interestingly, in ham-
sters the PRC to injections of anisomycin is qualitatively 
similar to those generated by injections of a short-acting 
benzodiazepine, triazolam, under conditions of either 
constant light or constant dark (27) . However, at the 
present time it is not known whether the phase-shifting 
effects of protein synthesis inhibitors and benzodiaze-
pines involve similar mechanisms. 
Mrosovsky (14) has obtained PRCs to cage changing 
and social interactions in hamsters that are similar in 
shape to those observed for anisomycin and triazolam. 
He has suggested that phase shifts in the circadian 
oscillator in response to drug treatment may be due in 
part to an alteration in the general arousal state of the 
organism. Indeed, exposure to a running wheel for a 
short period of time by itself can induce phase shifts in 
the activity rhythm of hamsters that are similar to those 
observed after treatment with anisomycin or triazolam 
(Wickland and Turek, unpublished results). However, it 
does not appear that phase shifts induced by injections 
of anisomycin are mediated through an increase in lo-
comotor activity. In the present study, an increase in 
activity for >30 min in response to injections of aniso-
mycin was only observed in -20% of the animals and no 
significant correlation between amount of activity, and 
phase shift was observed for any of the circadian times 
tested. Although only wheel-running behavior was re-
corded in the present study, visual observations of the 
animals indicate that there is no general increase in 
activity associated with injections of anisomycin. 
PRCs to pulse administration of protein synthesis 
inhibitors have been determined for a number of orga-
nisms, includingAplysia (10- 12, 16), Gonyaulax (25), and 
N eurospora (15). It is intriguing to note that the PRC to 
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anisomycin injected into the hamster SCN region has 
qualitative similarities with the PRCs to protein synthe-
sis inhibitors in Aplysia and Neurospora. The delay re-
gions of the PRCs for anisomycin in Aplysia and for 
cycloheximide in Neurospora both peak near CT 0. The 
advance regions are more variable. In Aplysia, anisomy-
cin produces either very small or undetectable phase 
advances near CT 6; whereas in Neurospora cyclohexi-
mide produces clear advances that peak at CT 6. Perhaps 
more importantly, the "breakpoints" (i.e., the transition 
from phase delays to phase advances) of the PRCs are 
clustered around CT 4 in Aplysia and Neurospora as well 
as in the hamster. These similarities may suggest that 
the molecular mechanisms generating circadian rhythms 
in the mammalian SCN share some common features 
with those found in diverse phylogenetic groups. 
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